The South Korean manufacturer and exporter of biosimilars said it has been designated as the preferred bidder on a large-scale cGMP drug substance facility.
While the drugmaker provided few details on the plan, a new restructuring program is meant to align its global manufacturing to reflect changes in the business.
Although some analysts do not expect it to have a significant financial impact, others project tariffs could increase industry costs by $13 billion to $19 billion per year.
President Donald Trump and European Commission President Ursula von der Leyen appear to differ on how their trade agreement addresses pharma-specific tariffs.
Marc Casper says the Ridgefield site, which specializes in fill‑finish and packaging of aseptic injectable medications, aligns with its plans to bolster U.S. capacity.
The company saw positive momentum in mammalian, bioconjugates, and small molecules, offsetting lower sales from its cell and gene therapy and microbial businesses.
CEO Pascal Soriot said the company’s capital expenditure will support its goal of reaching $80 billion in revenue by 2030, with 50% generated in the United States.
The expansion will make the Aachen, Germany-based biotech the largest producer of Human Platelet Lysate and create new skilled jobs in the region, according to the company.
Discover how automated calibration improves compliance, reduces human error, and increases efficiency in pharmaceutical manufacturing. This Beamex white paper explores the benefits...
Unlock the full potential of your GMP assets. Discover how life sciences organizations can optimize reliability, compliance, and performance with a data-driven approach to Asset...
Three of Cognite's chemical, refining, and energy customers take center stage in this product tour video that showcases why and how they are transforming their operations.
Are you making quick-enough progress on your industrial Gen AI journey? Learn what it actually takes to trust, deliver, and scale across operational use cases.
